회사 개요
Reinsurance Group of America, Incorporated is a leading provider of life and health, as well as asset-intensive reinsurance solutions, operating across a global footprint that includes the United States, Latin America, Canada, Europe, the Middle East, Africa, Asia, and Australia. The firm specializes in underwriting individual and group life and health policies, alongside disability, long-term care, and critical illness reinsurance products, serving as a critical intermediary within the broader risk transfer ecosystem. This entity functions within the Financial Services sector, specifically the Insurance - Reinsurance industry, where it assumes the risk and liability portfolios of primary insurers to facilitate capital formation and risk diversification. The company currently maintains a substantial market capitalization of $13.07B and generates annual revenue of $23.70B, employing approximately 4,300 personnel to support its extensive global operations. These valuation and revenue figures indicate that the company holds a significant position within the global reinsurance market, reflecting a large-scale infrastructure capable of managing complex, long-duration liabilities across diverse international jurisdictions.
재무 건전성
The company reported a Total Revenue of $23.70B for the trailing twelve months, resulting in a Net Income of $1.18B and an EBITDA of $1.95B. The substantial gap between the revenue of $23.70B and the net income of $1.18B reveals a cost structure characterized by significant operating expenses, including claims payments, loss adjustments, and overhead costs inherent to the insurance business model. However, the EBITDA of $1.95B suggests that when non-cash items like depreciation and interest are excluded, the underlying cash generation from operations is more robust than the net income figure alone might suggest. The Free Cash Flow stands at $1.80B, which provides the firm with considerable financial flexibility to meet capital expenditure requirements, service debt obligations, and potentially return capital to shareholders without relying on external financing. Profitability metrics show a Gross Margin of 13.7%, an Operating Margin of 9.2%, and a Profit Margin of 5.0%, indicating that while the business generates revenue, the leverage of fixed costs and the nature of underwriting losses constrain the bottom line relative to the top line. On the balance sheet, the company holds $4.51B in cash against $5.71B in total debt, resulting in a Debt to Equity ratio of 42.14, which suggests a moderately leveraged position typical for capital-intensive insurance firms. The Current Ratio of 1.26 indicates that the company possesses sufficient liquid assets to cover its short-term liabilities, pointing to a stable short-term liquidity profile. Return on Equity is recorded at 9.7% while Return on Assets is 0.9%, revealing that the company's equity base is significantly smaller than its total asset base, a characteristic feature of the insurance industry where policyholder liabilities dominate the balance sheet.
밸류에이션 평가
The stock carries a Trailing P/E ratio of 11.24 and a Forward P/E of 6.90, where the disparity between these two figures implies that the market expects earnings growth that would be required to justify the lower forward multiple. A Forward P/E of 6.90 is notably lower than the trailing P/E of 11.24, suggesting that analysts project a significant expansion in future earnings relative to current levels. The Price to Book ratio is 0.97, which indicates that the market values the company at approximately one dollar for every dollar of book value, implying no premium and potentially a discount relative to the tangible assets backing the liabilities. Alternative valuation metrics such as the Price to Sales ratio of 0.55 and an EV/EBITDA of 7.35 provide context that the stock is priced conservatively relative to its sales volume and enterprise earnings power. The 52-week price range spans from a low of $159.25 to a high of $229.21, and without a specific current price provided in the facts, the valuation is best understood within this historical volatility band defined by these extremes. The Beta of 0.50 indicates that the stock exhibits low price volatility relative to the broader market, moving at roughly half the magnitude of the market index during periods of fluctuation.
Growth & Income
Revenue growth for the year-over-year period is recorded at 26.6%, while earnings growth is significantly higher at 216.6%, implying that earnings are expanding much faster than revenue, likely driven by leverage effects, one-time gains, or normalization of prior underwriting results. The company maintains a Dividend Yield of 1.9% with a Payout Ratio of 20.6%, which suggests that the dividend payments are highly sustainable given the substantial earnings growth and the conservative payout level relative to current profits. The low payout ratio of 20.6% combined with the robust free cash flow of $1.80B indicates that the firm retains the majority of its earnings to strengthen its balance sheet and fund organic growth initiatives rather than maximizing immediate shareholder returns. The overall growth and income profile reflects a mature insurer experiencing a cyclical upturn in profitability, supported by strong cash generation and a disciplined approach to capital deployment.